MENU
+Compare
XOMA
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$24.76
Change
-$0.24 (-0.96%)
Capitalization
299.17M

XOMA XOMA Royalty Corporation Forecast, Technical & Fundamental Analysis

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more

Industry: #Biotechnology
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for XOMA with price predictions
Jun 04, 2025

Aroon Indicator for XOMA shows an upward move is likely

XOMA's Aroon Indicator triggered a bullish signal on May 29, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 185 similar instances where the Aroon Indicator showed a similar pattern. In of the 185 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOMA advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XOMA moved out of overbought territory on May 20, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XOMA as a result. In of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XOMA turned negative on May 22, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOMA broke above its upper Bollinger Band on May 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.537) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). XOMA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.020) settles around the average of (0.040) among similar stocks. P/S Ratio (25.381) is also within normal values, averaging (265.014).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XOMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XOMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

XOMA is expected to report earnings to fall 429.17% to -19 cents per share on August 06

XOMA Royalty Corporation XOMA Stock Earnings Reports
Q2'25
Est.
$-0.20
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.25
Q3'24
Missed
by $1.15
Q2'24
Beat
by $1.10
The last earnings report on May 13 showed earnings per share of 5 cents, beating the estimate of -28 cents. With 3.38K shares outstanding, the current market capitalization sits at 299.17M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical preparations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Powell Street
Phone
+1 510 204-7200
Employees
13
Web
https://www.xoma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMRGX7.570.07
+0.93%
Emerging Markets Equities Fund M
PNOCX82.71N/A
N/A
Putnam Sustainable Leaders C
FRSLX25.55N/A
N/A
Nuveen Small/Mid Cap Growth Opp A
CUURX51.14N/A
N/A
Columbia Small Cap Value I Inst2
MKSCX12.56N/A
N/A
BlackRock Sustainable Advantage Gbl Eq K

XOMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with GBIO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
+2.50%
GBIO - XOMA
39%
Loosely correlated
-2.86%
CRBU - XOMA
36%
Loosely correlated
+7.62%
ZNTL - XOMA
36%
Loosely correlated
+10.29%
NAUT - XOMA
36%
Loosely correlated
+0.92%
RCUS - XOMA
36%
Loosely correlated
-4.29%
More